| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |